Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 414

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial

Open access
Kar, Saibal, Doshi, Shephal K., Sadhu, Ashish, Horton, Rodney, Osorio, Jose, Ellis, Christopher, Stone, James, Shah, Manish, Dukkipati, Srinivas R., Adler, Stuart, Nair, Devi G., Kim, Jamie, Wazni, Oussama, Price, Mathew J., Asch, Federico M., Holmes, David R., Shipley, Robert D., Gordon, Nicole T., Allocco, Dominic J., Reddy, Vivek Y., On behalf of the PINNACLE FLX Investigators·2021·Circulation

Abstract

Background: Left atrial appendage (LAA) occlusion provides an alternative to oral anticoagulation for thromboembolic risk reduction in patients with nonvalvular atrial fibrillation. Since regulatory approval in 2015, the WATCHMAN device has been the only LAA closure device available for clinical use in the United States. The PINNACLE FLX study (Protection Against Embolism for Nonvalvular AF Patients: Investigational Device Evaluation of the Watchman FLX LAA Closure Technology) evaluated the safety and effectiveness of the next-generation WATCHMAN FLX LAA closure device in patients with nonvalvular atrial fibrillation in whom oral anticoagulation is indicated, but who have an appropriate rationale to seek a nonpharmaceutical alternative. Methods: This was a prospective, nonrandomized, multicenter US Food and Drug Administration study. The primary safety end point was the occurrence of one of the following events within 7 days after the procedure or by hospital discharge, whichever was later: death, ischemic stroke, systemic embolism, or device- or procedure-related events requiring cardiac surgery. The primary effectiveness end point was the incidence of effective LAA closure (peri-device flow ≤5 mm), as assessed by the echocardiography core laboratory at 12-month follow-up. Results: A total of 400 patients were enrolled. The mean age was 73.8±8.6 years and the mean CHA 2 DS 2 -VASc score was 4.2±1.5. The incidence of the primary safety end point was 0.5% with a 1-sided 95% upper CI of 1.6%, meeting the performance goal of 4.2% ( P <0.0001). The incidence of the primary effectiveness end point was 100%, with a 1-sided 95% lower CI of 99.1%, again meeting the performance goal of 97.0% ( P <0.0001). Device-related thrombus was reported in 7 patients, no patients experienced pericardial effusion requiring open cardiac surgery, and there were no device embolizations. Conclusions: LAA closure with this next-generation LAA closure device was associated with a low incidence of adverse events and a high incidence of anatomic closure. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02702271.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.120.050117

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 414

Metadata

Authors
Kar, S., Doshi, S. K., Sadhu, A., Horton, R., Osorio, J., Ellis, C., Stone, J., Shah, M., Dukkipati, S. R., Adler, S., Nair, D. G., Kim, J., Wazni, O., Price, M. J., Asch, F. M., Holmes, D. R., Shipley, R. D., Gordon, N. T., Allocco, D. J., Reddy, V. Y., & On behalf of the PINNACLE FLX Investigators
Venue
Circulation
Published
2021-05-04
Volume
143
Issue
18
Pages
1754-1762
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3150320039
Cited by
414
References
11
FWCI
43.99
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial. https://app.cochat.ai/papers/10.1161/circulationaha.120.050117
The paper
Kar, S., Doshi, S. K., Sadhu, A., Horton, R., Osorio, J., Ellis, C., Stone, J., Shah, M., Dukkipati, S. R., Adler, S., Nair, D. G., Kim, J., Wazni, O., Price, M. J., Asch, F. M., Holmes, D. R., Shipley, R. D., Gordon, N. T., Allocco, D. J., . . . On behalf of the PINNACLE FLX Investigators. (2021). Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial. Circulation. https://doi.org/10.1161/circulationaha.120.050117

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.